DMSO (dimethyl sulfoxide) and interstitial cystitis

What 4 graded rows on dmso (dimethyl sulfoxide) agree on for interstitial cystitis, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the DMSO (dimethyl sulfoxide) page, with its PubMed record.

Your question

DMSO (dimethyl sulfoxide) and interstitial cystitis

4 rows · 753 people

Mostly an improvement: 3 of 4 rows, and most of the people. 1 had mixed results.

Mixed
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside. Outlined: mixed results.
  • Grade B× 3
  • Grade C× 1
Rows
4
Trials
17
People
753
Pooled reviews may count some twice

What the rows share

From the rows

The best-graded row, grade B, is a meta-analysis of 554 people (2025) and found an improvement.

The rows run from 33 to 554 people, published from 1988 to 2025: 1 pooled review and 3 single studies.

The rows

3 improved · 1 mixed
  1. Grade BSymptom, problem and pain scores in interstitial cystitis (pooled) · Improved

    Meta-analysis, 14 studies · n 554 · 2025 · People with interstitial cystitis/bladder pain syndrome in 5 randomized trials and 9 single-arm or cohort studies

    As given in each included study · Varied by study

    Compared with before treatment, the symptom index fell 5.59 points, the problem index 5.14 points and pain scores 3.27 points (all p < 0.00001). Adverse events occurred in 37.6%, mostly mild.

    Row on the DMSO (dimethyl sulfoxide) page · PubMed 40205912 (opens PubMed)

  2. Grade BBladder pain and urinary symptoms in interstitial cystitis · Improved

    RCT · n 96 · 2021 · Japanese adults with bladder-centric interstitial cystitis/bladder pain syndrome (symptom index 9 or more, diagnosed by cystoscopy)

    One bladder instillation every 2 weeks · 12 weeks

    The O'Leary-Sant symptom index fell 5.2 points with DMSO vs 3.4 with placebo (difference −1.8, 95% CI −3.3 to −0.3; P = 0.0188). Bladder pain, urination frequency, voided volume and global response also improved more than with placebo; side effects were mild to moderate.

    Row on the DMSO (dimethyl sulfoxide) page · PubMed 33580603 (opens PubMed)

  3. Grade BSymptom and urodynamic improvement in interstitial cystitis · Improved

    Crossover RCT · n 33 · 1988 · 30 women and 3 men (mean age 48, symptoms for a mean 5.5 years) with biopsies suggestive of interstitial cystitis (Canada)

    One instillation every 2 weeks · Two sessions of 4 instillations each (crossover)

    53% were markedly improved on DMSO vs 18% on placebo (subjective), and 93% vs 35% improved on objective urodynamic measures. No significant side effects were noted.

    Row on the DMSO (dimethyl sulfoxide) page · PubMed 3288775 (opens PubMed)

  4. Grade CInterstitial cystitis symptoms: DMSO mix vs a bupivacaine, triamcinolone and heparin mix · Mixed

    RCT · n 70 · 2023 · Women with newly diagnosed interstitial cystitis/painful bladder syndrome (USA); 83 randomized, 70 completed all instillations

    Six weekly bladder instillations · 6 weeks

    A fall of more than 29.5% in the symptom index occurred in 63% with DMSO vs 43% with BTH (p = 0.15, not significant). Pain and night-time urination fell significantly more with DMSO; bladder capacity rose in both groups.

    Row on the DMSO (dimethyl sulfoxide) page · PubMed 36747494 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.